Screening, Brief Intervention, and Referral to Treatment for Pain Management for Veterans Seeking Service-Connection Payments for Musculoskeletal Disorders: SBIRT-PM Study Protocol

Abstract Background Veterans with significant chronic pain from musculoskeletal disorders are at risk of substance misuse. Veterans whose condition is the result of military service may be eligible for a disability pension. Department of Veterans Affairs compensation examinations, which determine the degree of disability and whether it was connected to military service, represent an opportunity to engage Veterans in pain management and substance use treatments. A multisite randomized clinical trial is testing the effectiveness and cost-effectiveness of Screening, Brief Intervention, and Referral to Treatment for Pain Management (SBIRT-PM) for Veterans seeking compensation for musculoskeletal disorders. This telephone-based intervention is delivered through a hub-and-spoke configuration. Design This study is a two-arm, parallel-group, 36-week, multisite randomized controlled single-blind trial. It will randomize 1,100 Veterans experiencing pain and seeking service-connection for musculoskeletal disorders to either SBIRT-PM or usual care across eight New England VA medical centers. The study balances pragmatic with explanatory methodological features. Primary outcomes are pain severity and number of substances misused. Nonpharmacological pain management and substance use services utilization are tracked in the trial. Summary Early trial enrollment targets were met across sites. SBIRT-PM could help Veterans, at the time of their compensation claims, use multimodal pain treatments and reduce existing substance misuse. Strategies to address COVID-19 pandemic impacts on the SBIRT-PM protocol have been developed to maintain its pragmatic and exploratory integrity.

[1]  M. Balcells-Oliveró,et al.  Validation of the Alcohol Smoking and Substance Involvement Screening Test (ASSIST) in acute psychiatric inpatients. , 2021, Adicciones.

[2]  B. Fenton,et al.  Access to Pain Care From Compensation Clinics: A Relational Coordination Perspective. , 2020, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

[3]  P. Peduzzi,et al.  NIH-DoD-VA Pain Management Collaboratory. , 2019, Pain medicine.

[4]  A. C. Black,et al.  Brief Counseling for Veterans with Musculoskeletal Disorder, Risky Substance Use, and Service Connection Claims , 2019, Pain medicine.

[5]  James M. Dahlhamer,et al.  Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016 , 2018, MMWR. Morbidity and mortality weekly report.

[6]  M. Helfand,et al.  Effectiveness of Models Used to Deliver Multimodal Care for Chronic Musculoskeletal Pain: a Rapid Evidence Review , 2018, Journal of General Internal Medicine.

[7]  T. Trikalinos,et al.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. , 2016, JAMA.

[8]  Joseph W. Frank,et al.  Evaluation of a telementoring intervention for pain management in the Veterans Health Administration. , 2015, Pain medicine.

[9]  P. Donnan,et al.  The PRECIS-2 tool: designing trials that are fit for purpose , 2015, BMJ : British Medical Journal.

[10]  S. Galvani.  Motivational Interviewing: Helping People Change (3rd edition) , 2014 .

[11]  T. Palfai,et al.  Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. , 2014, JAMA.

[12]  Luci K. Leykum,et al.  Implementation of the epilepsy center of excellence to improve access to and quality of care – protocol for a mixed methods study , 2014, Implementation Science.

[13]  J. Switzer,et al.  Cost utility of hub-and-spoke telestroke networks from societal perspective. , 2013, The American journal of managed care.

[14]  J. Switzer,et al.  Cost-Effectiveness of Hub-and-Spoke Telestroke Networks for the Management of Acute Ischemic Stroke From the Hospitals’ Perspectives , 2013, Circulation. Cardiovascular quality and outcomes.

[15]  R. Kerns,et al.  Implementation of the Veterans Health Administration National Pain Management Strategy , 2011, Translational behavioral medicine.

[16]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[17]  D. Turk,et al.  Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder , 2011, PAIN®.

[18]  D. Turk,et al.  Association between substance use disorder status and pain-related function following 12 months of treatment in primary care patients with musculoskeletal pain. , 2011, The journal of pain : official journal of the American Pain Society.

[19]  J. Potter,et al.  A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. , 2010, Contemporary clinical trials.

[20]  Ian Harvey,et al.  A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers , 2009, Canadian Medical Association Journal.

[21]  S. Asch,et al.  Development and Initial Validation of the PEG, a Three-item Scale Assessing Pain Intensity and Interference , 2009, Journal of General Internal Medicine.

[22]  C. Furberg,et al.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. , 2009, Journal of clinical epidemiology.

[23]  K. Carroll,et al.  Community program therapist adherence and competence in motivational enhancement therapy. , 2008, Drug and alcohol dependence.

[24]  Robert J Volk,et al.  AUDIT-C as a brief screen for alcohol misuse in primary care. , 2007, Alcoholism, clinical and experimental research.

[25]  D. Svikis,et al.  Computer-based brief intervention a randomized trial with postpartum women. , 2007, American journal of preventive medicine.

[26]  K. Humphreys,et al.  Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. , 2004, Drug and alcohol dependence.

[27]  Anirban Basu,et al.  Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data , 2003, Journal of health economics.

[28]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[29]  R L Stout,et al.  Ensuring balanced distribution of prognostic factors in treatment outcome research. , 1994, Journal of studies on alcohol. Supplement.

[30]  C. Cleeland,et al.  Pain assessment: global use of the Brief Pain Inventory. , 1994, Annals of the Academy of Medicine, Singapore.

[31]  A. Zbrozek,et al.  The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument , 1993, PharmacoEconomics.

[32]  D. Cox,et al.  An Analysis of Transformations , 1964 .

[33]  G. Fitzmaurice,et al.  Denial of urinalysis-confirmed opioid use in prescription opioid dependence. , 2015, Journal of substance abuse treatment.

[34]  Bradley E. Karlin,et al.  From the laboratory to the therapy room: National dissemination and implementation of evidence-based psychotherapies in the U.S. Department of Veterans Affairs Health Care System. , 2014, The American psychologist.

[35]  S. Sullivan,et al.  Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[36]  Veterans Affairs.  Department of Veterans Affairs. , 1998, Medical care.

[37]  Paul Karoly,et al.  Self-report scales and procedures for assessing pain in adults , 1992 .